Oncodesign Services
- Other R&D services
- CMO, CRO
Oncodesign Services-ZoBio Group partners with biopharma and biotech innovators to advance drug discovery from hit identification to preclinical candidate selection. We offer integrated and standalone services in structural biology, fragment-based screening, medicinal chemistry, DMPK, bioanalysis, and pharmacology, including research models and cutting-edge pharmaco-imaging. Our expertise spans oncology, immuno-oncology, inflammatory diseases, and radiopharmaceutical development. With proven success in diverse MoAs, including PROTACs, PPIs, and enzyme modulators, we bring flexible, expert-driven support to accelerate your R&D. Our 280-strong team collaborates globally with pharma, biotech, and academia to enable breakthrough therapies.